Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 6274 | 1441 | 29.2 | 75% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 540 | 13989 | FLUOROQUINOLONES//CIPROFLOXACIN//QUINOLONES |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | GEMIFLOXACIN | Author keyword | 59 | 59% | 5% | 66 |
| 2 | GEMIFLOXACIN MESYLATE | Author keyword | 44 | 100% | 1% | 16 |
| 3 | GARENOXACIN | Author keyword | 22 | 58% | 2% | 25 |
| 4 | BAY 12 8039 | Author keyword | 11 | 100% | 0% | 6 |
| 5 | DW286 | Author keyword | 9 | 83% | 0% | 5 |
| 6 | NEMONOXACIN | Author keyword | 9 | 83% | 0% | 5 |
| 7 | MOXIFLOXACIN | Author keyword | 9 | 11% | 5% | 74 |
| 8 | ZABOFLOXACIN | Author keyword | 8 | 100% | 0% | 5 |
| 9 | TROVAFLOXACIN | Author keyword | 8 | 31% | 2% | 22 |
| 10 | DELAFLOXACIN | Author keyword | 6 | 80% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | GEMIFLOXACIN | 59 | 59% | 5% | 66 | Search GEMIFLOXACIN | Search GEMIFLOXACIN |
| 2 | GEMIFLOXACIN MESYLATE | 44 | 100% | 1% | 16 | Search GEMIFLOXACIN+MESYLATE | Search GEMIFLOXACIN+MESYLATE |
| 3 | GARENOXACIN | 22 | 58% | 2% | 25 | Search GARENOXACIN | Search GARENOXACIN |
| 4 | BAY 12 8039 | 11 | 100% | 0% | 6 | Search BAY+12+8039 | Search BAY+12+8039 |
| 5 | DW286 | 9 | 83% | 0% | 5 | Search DW286 | Search DW286 |
| 6 | NEMONOXACIN | 9 | 83% | 0% | 5 | Search NEMONOXACIN | Search NEMONOXACIN |
| 7 | MOXIFLOXACIN | 9 | 11% | 5% | 74 | Search MOXIFLOXACIN | Search MOXIFLOXACIN |
| 8 | ZABOFLOXACIN | 8 | 100% | 0% | 5 | Search ZABOFLOXACIN | Search ZABOFLOXACIN |
| 9 | TROVAFLOXACIN | 8 | 31% | 2% | 22 | Search TROVAFLOXACIN | Search TROVAFLOXACIN |
| 10 | DELAFLOXACIN | 6 | 80% | 0% | 4 | Search DELAFLOXACIN | Search DELAFLOXACIN |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CP 99 219 | 82 | 65% | 5% | 79 |
| 2 | FLUORONAPHTHYRIDONE | 81 | 83% | 3% | 45 |
| 3 | DNA TOPOISOMERASE IV | 66 | 64% | 5% | 65 |
| 4 | BAY 12 8039 | 56 | 49% | 6% | 83 |
| 5 | PARC | 47 | 41% | 6% | 88 |
| 6 | TOPOISOMERASE IV | 46 | 26% | 11% | 153 |
| 7 | LB20304 | 46 | 72% | 2% | 36 |
| 8 | BMS 284756 | 35 | 67% | 2% | 32 |
| 9 | FLUOROQUINOLONE | 35 | 22% | 10% | 143 |
| 10 | 8 METHOXYQUINOLONE | 31 | 49% | 3% | 46 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| The fluoroquinolone antibacterials: past, present and future perspectives | 2000 | 258 | 37 | 59% |
| A critical review of the fluoroquinolones - Focus on respiratory tract infections | 2002 | 151 | 302 | 50% |
| Resistance surveillance studies: a multifaceted problem-the fluoroquinolone example | 2012 | 28 | 227 | 28% |
| A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance | 2005 | 93 | 24 | 50% |
| Fluoropuinolone resistance among Gram-positive cocci | 2002 | 150 | 104 | 39% |
| Quinolones in 2005: an update | 2005 | 143 | 250 | 28% |
| Pharmacokinetics, safety and tolerability of moxifloxacin, a novel 8-methoxyfluoroquinolone, after repeated oral administration | 2001 | 45 | 8 | 88% |
| Moxifloxacin - A review of its use in the management of bacterial infections | 2004 | 40 | 131 | 58% |
| In vitro antibacterial activity and phamacodynamics of new quinolones | 2003 | 77 | 93 | 51% |
| Moxifloxacin - A review of its clinical potential in the management of community-acquired respiratory tract infections | 2000 | 76 | 64 | 61% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | UNIDAD GENET BACTERIANA | 5 | 39% | 0.8% | 11 |
| 2 | PMS MANAGEMENT | 4 | 75% | 0.2% | 3 |
| 3 | PATHOL CLIN MICROBIOL | 4 | 33% | 0.7% | 10 |
| 4 | RM ALDEN | 2 | 22% | 0.6% | 9 |
| 5 | CNR PNEUMOCOQUES | 2 | 67% | 0.1% | 2 |
| 6 | GEN BASIC MED SCI | 2 | 67% | 0.1% | 2 |
| 7 | PHARMACOKINET EARLY CLIN EXPT MED | 2 | 67% | 0.1% | 2 |
| 8 | SASKATOON DIST HLTH | 2 | 67% | 0.1% | 2 |
| 9 | JMI S | 2 | 16% | 0.8% | 12 |
| 10 | EIJKMAN WINKLER MED MICROBIOL | 2 | 19% | 0.7% | 10 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000180214 | BURNS TRAUMA CRIT CARE//MUTANT SELECTION WINDOW//ANTIINFECT DEV |
| 2 | 0.0000168307 | TELITHROMYCIN//MACROLIDE RESISTANCE//CEFDITOREN |
| 3 | 0.0000152844 | PRULIFLOXACIN//ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS//ACUTE EXACERBATION OF CHRONIC BRONCHITIS |
| 4 | 0.0000140538 | LB20304//AT 4140//TEMAFLOXACIN |
| 5 | 0.0000118379 | PENICILLIN RESISTANCE//PENICILLIN RESISTANT PNEUMOCOCCI//EENHEID ANTIBIOT ONDERZOEK |
| 6 | 0.0000116884 | ANTOFLOXACIN HYDROCHLORIDE//SKELETAL TOXICITY//ANTOFLOXACIN |
| 7 | 0.0000115648 | N SUBSTITUTED PIPERAZINYL QUINOLONES//PIPERAZINYL QUINOLONES//S ENOKI 3394 |
| 8 | 0.0000109980 | QNR//QEPA//AAC6 IB CR |
| 9 | 0.0000100358 | DNA GYRASE//GYRASE//REVERSE GYRASE |
| 10 | 0.0000080020 | INTERACTION WITH CALF THYMUS DNA//COMPETITIVE STUDIES WITH ETHIDIUM BROMIDE//NORFLOXACIN |